Labshake search
Citations for R&D Systems :
351 - 400 of 3933 citations for 4 Methoxy 2 2 3 4 5 5 Hexacb 13C12 99% 50 Ug Ml In Toluene since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2019Quote: ... Addition of 20 ng/ml BMP-4 (R&D Systems, 314-BP-05/C) on day 0 (removed on day 7) ...
-
bioRxiv - Immunology 2020Quote: ... 4 ng/ml human transforming growth factor α (TGFα; R&D Systems, MN, USA) as a positive control ...
-
bioRxiv - Immunology 2020Quote: ... monocytes were cultured with 250 U/ml IL-4 (R&D Systems, Minneapolis, MN) and 800 U/mL GM-CSF (R&D Systems ...
-
bioRxiv - Microbiology 2020Quote: ... followed by 4 days with 200ng/ml Noggin (R&D Systems, 6057-NG-100), 500ng/ml FGF4 (Peprotech ...
-
bioRxiv - Neuroscience 2022Quote: Pentraxins Binding C1q Purified recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems) or IgM (2 µg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... 10 ng mL− 1 BMP-4 (human recombinant) (R&D Systems, Minneapolis, MN, USA), 10 µM LY294002 (Cayman Chemical ...
-
bioRxiv - Cell Biology 2023Quote: ... followed by treatment with 30 ng/mL each Il-4 (R&D Systems; 404ML010) and IL-13 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Microbiology 2020Quote: ... Sigma Aldrich)] or M2-activation medium [RPMI160 medium with 20 ng/ml IL-4 (404-ML-010; R&D systems) and 100 ng/ml MCSF (416-ML-010 ...
-
bioRxiv - Cell Biology 2020Quote: ... and HHIP (Cat#9280-HP-050; R&D Systems; used 5 μg/mL) were added to the media after 48 hours and replenished in every media change ...
-
bioRxiv - Neuroscience 2020Quote: ... and 5 ng/mL of basic fibroblast growth factor (bFGF; R&D Systems) on 0.1% gelatin coated dishes with irradiated mouse embryonic fibroblast (iMEFs).
-
bioRxiv - Cell Biology 2021Quote: ... and 5 ng/mL TGF-β (R&D Systems, cat# 240-B-002). To test the effect of FYN depletion on collagen deposition ...
-
bioRxiv - Cell Biology 2019Quote: ... HUVE cells were seeded on fibronectin-coated (5 μg/mL, R&D Systems) No ...
-
bioRxiv - Immunology 2022Quote: ... and 5 ng/ml TGF-β1 (R&D Systems, Bio-Techne, Wiesbaden, Germany) for 72 hours.
-
bioRxiv - Cancer Biology 2022Quote: ... 5 μg/mL Tenascin-C (Cat no. 3358-TC-050, R&D Systems) coated ...
-
bioRxiv - Biophysics 2023Quote: ... 5 ng/ml of recombinant mouse interleukin-1β (IL-1β, R&D Systems), and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ ...
-
bioRxiv - Cell Biology 2022Quote: ... BMDMs were treated with 100 ng/mL mouse IFNγ or 5 U/mL IFNα (R&D Systems) for 2 ...
-
bioRxiv - Bioengineering 2021Quote: ... After 48 hours the cells were fed with stage 2 differentiation medium consisting of STEMDiff APEL supplemented with 50 ng/mL of VEGF 165 (R&D Systems, 293-VE-010), 25 ng/mL of BMP4 (R&D Systems ...
-
bioRxiv - Microbiology 2021Quote: ... 5 x 107 cells per sample were washed with FACS buffer (1x PBS supplemented with 2% FBS and 1 mM EDTA) and incubated with 50 µg/mL SARS-CoV-2 spike S1 subunit-Fc fusion protein (R&D systems, #10623-CV-100) or human IgG1 isotype control (BioXCell ...
-
bioRxiv - Immunology 2019Quote: ... and homogenates were diluted to 2 mg/mL protein in PBS and were subsequently diluted 1:2 in Reagent Diluent (R&D Systems). CXCL10 protein was quantified using the Mouse CXCL10 Duoset ELISA kit (R&D Systems ...
-
bioRxiv - Bioengineering 2019Quote: ... 2013] consisting of the osteogenic media supplemented with 100 ng/mL BMP-2 (recombinant human BMP-2, 355-BM-050, R&D Systems). Media was replaced every 3 days ...
-
bioRxiv - Immunology 2022Quote: ... Frozen PBMC of post-CA patients were thawed and incubated in the media (RPMI1640 +2% FBS) with human anti-Nectin-2 monoclonal antibody or isotype control (20 μg/mL, both R&D Systems) for 6h ...
-
bioRxiv - Immunology 2021Quote: ... were measured by flow cytometry 2 days after activation with or without an extra stimulation with 25 ng/mL IL-2 (R&D Systems) during 15 min.
-
bioRxiv - Bioengineering 2022Quote: ... The cells were then cultured with bone morphogenic protein-4 (BMP-4; R&D Systems) and CHIR-99021 in RPMI-B27 medium to specify for cardiac mesoderm lineages ...
-
bioRxiv - Neuroscience 2020Quote: ... 2 ng/ml Nrg1 (human NRG1-β1 extracellular domain, R&D Systems), and 2 μM forskolin ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5ng/ml IL-2(# 202-IL-050/CF, R&D Systems). Activated CD3+ T cells were isolated from Dynabead Mouse T Activator CD3/CD28 (#00775477 ...
-
bioRxiv - Bioengineering 2022Quote: ... and human fibroblast growth factor 2 (20 ng/mL, R&D Systems). hECSR was added to the bottom channel prior to addition of cells into the well ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 mM L-glutamine and 20 ng/ml BDNF (R&D Systems). In each group (control and Celsr2 mutant) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2) TGFβ2 (TGFβ2: 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA) for 0-5 d followed by vehicle control (0.1% DMSO ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
bioRxiv - Bioengineering 2020Quote: ... Collagen gel loaded with BMP-2 (75 μg/mL, R&D Systems) was used as a positive control ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2(R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2 (R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Immunology 2020Quote: ... Pen-Strep and human recombinant interleukin-2 (210U/mL, R&D systems). For activation ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng/mL FGF-2 (R&D Systems, 233-FB-010). Media changes were performed every 48 hours and cells were allowed to proliferate ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng/mL FGF-2 (R&D Systems, 233-FB-010) on days 7 to 25 ...
-
bioRxiv - Neuroscience 2022Quote: ... and 2 µg/mL laminin (LM, R&D systems, 3400-010-02).
-
bioRxiv - Immunology 2022Quote: ... in the presence of IL-2 (100 U/ml, R&D Systems) and IL-7 (50 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... and recombinant human IL-2 (rhIL2,50 U/mL; R&D Systems/CellGenix)) with or without 1% penicillin/streptomycin/l-glutamine (Invitrogen) ...
-
bioRxiv - Immunology 2023Quote: ... were diluted to 4 µg/ml in PBS along with 1 µg/ml VCAM-1-Fc (R&D Systems). To coat ...
-
bioRxiv - Immunology 2023Quote: ... the pellets obtained after centrifugation of the BAL fluid were pooled and stained for 30 min at 4°C with unconjugated polyclonal goat anti-mouse Ym1/2 (AF2446, R&D Systems; 1:100 diluted in PBS). After washing ...
-
bioRxiv - Immunology 2022Quote: ... at a final concentration of 60 pmol/peptide/mL in CTLm supplemented with 400 U/mL IL-4 and 10 ng/mL IL-7 (R&D Systems) for three days ...
-
bioRxiv - Microbiology 2020Quote: ... cells were pre-treated with IL-4 (200 U/ml) (R&D Systems, Minneapolis, MN) for 12h at 37°C and then stimulated and infected as above ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4 mg/ml Collagen-I (Cultrex 3D rat tail collagen-I, R&D systems) on ice ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL of IL-2 and 10 ng/mL of IL-12 (R&D systems, 419-ML-010)) ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with increasing doses of TGFβ2 (vehicle control, 1.25 ng/ml, 2.5 ng/ml, and 5 ng/ml; R&D Systems, Minneapolis, MN) for 48 h ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 5 ng mL-1 of IL-7 and IL-15 (R&D Systems). Regulatory T cells were activated at 1 x 106 cells mL-1 for 2 days in complete XVivo15 supplemented with magnetic Treg Xpander CTS Dynabeads (ThermoFisher ...
-
bioRxiv - Neuroscience 2020Quote: ... then labelled with and without anti-human LILRB2 (5 µg/mL; R&D Systems). The cells were washed with PBS (0.5% BSA ...
-
bioRxiv - Cell Biology 2022Quote: ... together with human vascular endothelial growth factor (hVEGF, 5 ng/ml; R&D Systems). Cardiac specification was induced by exposure of cells to StemPro-34 SF medium (Gibco ...